Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.96 |
| ▸ | LTA4H | P09960 | 1/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.74 |
| ▸ | CCR3 | P51677 | 2/20 | 0.73 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.73 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.70 |
| ▸ | HRH1 | P35367 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7366514 | 0.98 | SIGMAR1 (1.00) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL10601122 | 0.98 | SIGMAR1 (0.96) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL113897 | 0.98 | SIGMAR1 (0.96) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL492561 | 0.96 | SIGMAR1 (1.00) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL8091557 | 0.96 | SIGMAR1 (1.00) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| Hydrochloric Acid SCHEMBL11555128 | 0.94 | SIGMAR1 (0.96) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL28881215 | 0.94 | SIGMAR1 (0.93) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL5302082 | 0.94 | LTA4H (0.86) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL83687 | 0.92 | SIGMAR1 (0.86) | SIGMAR1LTA4HSLC6A3CCR3GRIN2B | |
| SCHEMBL20382580 | 0.90 | LTA4H (0.86) | SIGMAR1LTA4HSLC6A3GRIN2BHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219465-A2 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme Inc (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-108024992-A | Aryl, Heteroaryl and Heterocyclic Compounds for the Treatment of Medical Disorders | 艾其林医药公司 | 2018-05-11 | — | — | CN | disclosed |
| US-5556876-A | ANTICHOLESTEROL AGENTS USING DERIVATIVES OF BENZOTHIENYL KETONES | ELI LILLY AND COMPANY (US) | 1996-09-17 | — | — | US | disclosed |
| US-5552433-A | ADMINISTERING SPECIFIED COMPOUND TO A HUMAN | ELI LILLY AND COMPANY (US) | 1996-09-03 | — | — | US | disclosed |
| US-5521172-A | BENZOTHIOPHENE KETONES WITH BENZENE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1996-05-28 | — | — | US | disclosed |
| US-5482950-A | BENZOTHIOPHENE DERIVATIVE | ELI LILLY AND COMPANY (US) | 1996-01-09 | — | — | US | disclosed |
| US-5480904-A | BENZOTHIOPHENE COMPOUND | ELI LILLY AND COMPANY (US) | 1996-01-02 | — | — | US | disclosed |
| US-5441964-A | Especially post-memopausal women | ELI LILLY AND COMPANY (US) | 1995-08-15 | — | — | US | disclosed |
| EP-0657162-A1 | Methods for lowering serum cholesterol | ELI LILLY AND COMPANY (US) | 1995-06-14 | — | — | EP | disclosed |
| EP-0651998-A1 | Methods for inhibiting bone loss | ELI LILLY AND COMPANY (US) | 1995-05-10 | — | — | EP | disclosed |
| EP-0650724-A1 | Methods for inhibiting uterine fibrosis | ELI LILLY AND COMPANY (US) | 1995-05-03 | — | — | EP | disclosed |
| EP-0164706-B1 | PHENYLALKYL AMINE BIOREGULATORS | BASF Aktiengesellschaft (DE) | 1989-04-05 | — | — | EP | disclosed |